Renin-angiotensin system and cardiovascular risk – Authors reply
暂无分享，去创建一个
[1] M. Pfeffer,et al. Impact of candesartan on nonfatal myocardial infarction and cardiovascular death in patients with heart failure. , 2005, JAMA.
[2] Karl Swedberg,et al. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. , 2003, The New England journal of medicine.
[3] K. Dickstein,et al. Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial , 2002, The Lancet.
[4] J. Rouleau,et al. Angiotensin receptor blockers: powerful evidence with cardiovascular outcomes? , 2002, The Canadian journal of cardiology.